Target intelligence / Profile preview

Protocadherin alpha-5 (PCDHA5)

Target
PCDHA5
Molecular classification
Cadherin superfamily, Clustered protocadherins, Cell adhesion protein, Integral membrane protein
01

Overview

Protocadherin alpha-5 (PCDHA5) is a member of the protocadherin alpha gene cluster, part of the cadherin superfamily of calcium-dependent cell-adhesion proteins. PCDHA5 is one of 15 closely related genes organized in tandem on human chromosome 5, with a unique genomic cluster arrangement reminiscent of immune receptor gene clusters. The protein contains six extracellular cadherin repeats (ectodomains), a single transmembrane region, and a cytoplasmic domain encoded by shared exons within the alpha cluster. PCDHA5 and related protocadherins are believed to play a critical role in establishing and maintaining specific neuronal connections and neural circuits in the brain via cell-cell adhesion mechanisms. Dysregulation or genetic variation of PCDHA5 has been associated with neurodevelopmental disorders such as autism spectrum disorders and may also be implicated in certain cancers, including prostate cancer. There are currently no known drugs directly targeting PCDHA5, nor is it considered a therapeutic drug target or receptor in clinical use.

Other names
CNRS6CNR6CRNR6CNRN6PCDH-alpha-5PCDH-ALPHA5KIAA0345-like 9ortholog of mouse CNR6
02

Biological functions

Calcium-dependent cell adhesionNeuron-neuron connectionNeural circuit formationCell-cell recognition
03

Disease associations

Neurodevelopmental disordersCancer (notably associations with prostate cancer and autism spectrum disorder)

Beyond the preview

Go deeper on Protocadherin alpha-5 (PCDHA5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protocadherin alpha-5 (PCDHA5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call